About AFT Pharmaceuticals
AFT Pharmaceuticals is a company based in Auckland (New Zealand) founded in 1997. The company has 119 employees as of March 31, 2024. AFT Pharmaceuticals has completed 3 acquisitions, including Angelini Pharma, Expanscience and Therabel. AFT Pharmaceuticals offers products and services including Maxigesic and Generic Drugs.
- Headquarter Auckland, New Zealand
- Employees 119 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aft Pharmaceuticals Ltd.
-
Annual Revenue
$116.62 M (USD)6.45as on Mar 31, 2024
-
Net Profit
$6.7 M (USD)-23.36as on Mar 31, 2024
-
EBITDA
$10.97 M (USD)-23.93as on Mar 31, 2024
-
Latest Funding Round
$48.24 M (USD), Post-IPO
Jun 11, 2020
-
Investors
CRG
& 1 more
-
Employee Count
119
as on Mar 31, 2024
-
Investments & Acquisitions
Angelini Pharma
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of AFT Pharmaceuticals
AFT Pharmaceuticals is a publicly listed company on the NZX with ticker symbol AFT in New Zealand, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of AFT Pharmaceuticals
AFT Pharmaceuticals offers a comprehensive portfolio of products and services, including Maxigesic and Generic Drugs.
Maxigesic is developed as a combination analgesic that is distributed through licensing agreements for pain management purposes.
Generic drugs are offered as part of a portfolio that includes in-licensed and patented options for various health needs.
People of AFT Pharmaceuticals
Unlock access to complete
Unlock access to complete
Funding Insights of AFT Pharmaceuticals
Investors in AFT Pharmaceuticals
AFT Pharmaceuticals has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include CRG and Milford Asset Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CRG is recognized as a premier healthcare investment partner.
|
Locked | Locked | Locked | |
|
Milford Asset Management is engaged in investment and wealth management.
|
Locked | Locked | Locked |
Investor details for AFT Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AFT Pharmaceuticals
AFT Pharmaceuticals has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Angelini Pharma, Expanscience and Therabel.
Investment portfolio details for AFT Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Dermo-cosmetic products, pharmaceutical drugs, and cosmetic active ingredients are developed.
|
Locked | Locked | 1950 | Locked | |
|
Pharmaceutical products are provided through industry partnerships for distribution.
|
Locked | Locked | 1945 | Locked | |
|
Manufacturer and developer of active ingredients, branded drugs, medical products and dietary supplements
|
Locked | Locked | 1919 | Locked |
Complete acquisition details for AFT Pharmaceuticals
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - AFT Pharmaceuticals
Detailed financials for AFT Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aft Pharmaceuticals Comparisons
Peer comparison for AFT Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AFT Pharmaceuticals
Detailed competitors of AFT Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aft Pharmaceuticals
Complete news archive for AFT Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AFT Pharmaceuticals
AFT Pharmaceuticals was founded in 1997 and raised its 1st funding round 17 years after it was founded.
AFT Pharmaceuticals is headquartered in Auckland, New Zealand.
As of Mar 31, 2024, the latest employee count at AFT Pharmaceuticals is 119.
Annual revenue of AFT Pharmaceuticals is $116.62M as on Mar 31, 2024.
Founded in 1997 and based in Auckland, New Zealand, operations in the pharmaceutical sector are conducted. Proprietary and in-licensed products, including patented, branded, and generic drugs, are developed and distributed. Research and development efforts are directed toward innovative solutions for unmet healthcare needs, with analgesics and eye care items featured in the portfolio. Out-licensing agreements are utilized for international distribution.
AFT Pharmaceuticals offers Maxigesic and Generic Drugs.
Yes, AFT Pharmaceuticals is publicly traded on NZX under the ticker symbol AFT.
AFT Pharmaceuticals has made 3 acquisitions, including Angelini Pharma, Expanscience, and Therabel.
AFT Pharmaceuticals has 2 investors. Key investors include CRG, and Milford Asset Management.
The ticker symbol of AFT Pharmaceuticals is AFT on NZX.